Literature DB >> 33058892

Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

Jacqueline Bezençon1, Chitra Saran2, Janine Hussner3, James J Beaudoin1, Yueping Zhang4, Hong Shen4, John K Fallon5, Philip C Smith5, Henriette E Meyer Zu Schwabedissen3, Kim L R Brouwer6.   

Abstract

Recent studies have focused on coproporphyrin (CP)-I and CP-III (CPs) as endogenous biomarkers for organic anion transporting polypeptides (OATPs). Previous data showed that CPs are also substrates of multidrug resistance-associated protein (MRP/Mrp) 2 and 3. This study was designed to examine the impact of loss of Mrp2 function on the routes of excretion of endogenous CPs in wild-type (WT) Wistar compared to Mrp2-deficient TR- rats. To exclude possible confounding effects of rat Oatps, the transport of CPs was investigated in Oatp-overexpressing HeLa cells. Results indicated that CPs are substrates of rodent Oatp1b2, and that CP-III is a substrate of Oatp2b1. Quantitative targeted absolute proteomic (QTAP) analysis revealed no differences in Oatps, but an expected significant increase in Mrp3 protein levels in TR- compared to WT rat livers. CP-I and CP-III concentrations measured by LC-MS/MS were elevated in TR- compared to WT rat liver, while CP-I and CP-III estimated biliary clearance was decreased 75- and 840-fold in TR- compared to WT rats, respectively. CP-III concentrations were decreased 14-fold in the feces of TR- compared to WT rats, but differences in CP-I were not significant. In summary, the disposition of CPs was markedly altered by loss of Mrp2 and increased Mrp3 function as measured in TR- rats.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker(s); Disease effect(s); Membrane transport; Multidrug resistance-associated protein(s) (MRP); Organic anion transporting polypeptide(s) (OATP); Proteomic; Transporter(s)

Mesh:

Substances:

Year:  2020        PMID: 33058892      PMCID: PMC7767637          DOI: 10.1016/j.xphs.2020.10.017

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  44 in total

1.  Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liver-specific transporter-1 (rlst-1) in rat liver.

Authors:  V Cattori; B Hagenbuch; N Hagenbuch; B Stieger; R Ha; K E Winterhalter; P J Meier
Journal:  FEBS Lett       Date:  2000-06-02       Impact factor: 4.124

2.  Comparison of five commercial extraction kits for subsequent membrane protein profiling.

Authors:  Stefanie Bünger; Uwe J Roblick; Jens K Habermann
Journal:  Cytotechnology       Date:  2010-01-14       Impact factor: 2.058

3.  Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease.

Authors:  Anna Vildhede; Emi Kimoto; Ryan M Pelis; A David Rodrigues; Manthena V S Varma
Journal:  Clin Pharmacol Ther       Date:  2019-12-26       Impact factor: 6.875

4.  Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome.

Authors:  S Toh; M Wada; T Uchiumi; A Inokuchi; Y Makino; Y Horie; Y Adachi; S Sakisaka; M Kuwano
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

5.  Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and/or P-glycoprotein.

Authors:  Yoshiyuki Shirasaka; Kensuke Suzuki; Takeo Nakanishi; Ikumi Tamai
Journal:  J Pharm Sci       Date:  2011-04-24       Impact factor: 3.534

6.  Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.

Authors:  James J Beaudoin; Jacqueline Bezençon; Noora Sjöstedt; John K Fallon; Kim L R Brouwer
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

7.  Disposition of oral and intravenous pravastatin in MRP2-deficient TR- rats.

Authors:  Kari T Kivistö; Olaf Grisk; Ute Hofmann; Konrad Meissner; Klaus-Uwe Möritz; Christoph Ritter; Katja A Arnold; Dieter Lutjöohann; Klaus von Bergmann; Ingrid Klöting; Michel Eichelbaum; Heyo K Kroemer
Journal:  Drug Metab Dispos       Date:  2005-08-17       Impact factor: 3.922

8.  Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans.

Authors:  Isabelle Benz-de Bretagne; Renaud Respaud; Patrick Vourc'h; Jean-Michel Halimi; Agnès Caille; Jean-Sébastien Hulot; Christian R Andres; Chantal Le Guellec
Journal:  J Biomed Biotechnol       Date:  2011-03-14

9.  Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics.

Authors:  Bhagwat Prasad; Katherine Johnson; Sarah Billington; Caroline Lee; Git W Chung; Colin D A Brown; Edward J Kelly; Jonathan Himmelfarb; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2016-09-12       Impact factor: 3.922

10.  Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and Simulation.

Authors:  Shelby Barnett; Kayode Ogungbenro; Karelle Ménochet; Hong Shen; Yurong Lai; W Griffith Humphreys; Aleksandra Galetin
Journal:  Clin Pharmacol Ther       Date:  2018-01-17       Impact factor: 6.875

View more
  1 in total

1.  Monocrotaline Toxicity Alters the Function of Hepatocyte Membrane Transporters in Rats.

Authors:  Catherine M Pastor; Valérie Vilgrain
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.